格隆汇5月13日|美国总统唐纳德·特朗普降低美国处方药价格的行政令所引发的担忧缓解,亚洲制药公司股价出现反弹,分析师表示,该行政命令的实施将会很困难。特朗普的目标是让制药商坐到谈判桌前,他周一签署的行政命令要求制药商自愿降低价格,否则将面临监管措施。分析师认为,该命令含糊不清,力度比制药公司最初预期的要弱。日本市场方面,日本第一三共上涨7.8%,武田制药涨4.7%,安斯泰来制药涨4.8%,卫材涨...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.